U.S., Aug. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07786779) titled 'A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Profile of YKYY033 Injection' on Aug. 23.

Brief Summary: A phase 1 study to evaluate the safety and tolerability of a single administration of YKYY033 injection in healthy adult participants

Study Start Date: July 10

Study Type: INTERVENTIONAL

Condition: Venous Thromboembolism (VTE)

Intervention: DRUG: YKYY033 Injection

subcutaneous injection, a single subcutaneous injection of the corresponding dose of YKYY033 injection

DRUG: YKYY033 Placebo

subcutaneous injection, a single subcutaneous injection of the corresponding dose of YKYY033...